Investigating clues of cystoid macular edema from a vascular perspective under long-term latanoprost usage.

IF 1.4 4区 医学 Q3 OPHTHALMOLOGY
Cansu Yuksel Elgin, Ilayda Kaner Savci, Yildiz Birisik, Mustafa Hepokur
{"title":"Investigating clues of cystoid macular edema from a vascular perspective under long-term latanoprost usage.","authors":"Cansu Yuksel Elgin, Ilayda Kaner Savci, Yildiz Birisik, Mustafa Hepokur","doi":"10.1007/s10792-025-03556-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess the macular vascular effects of prolonged use of latanoprost compared to the dorzolamide-timolol fixed combination in patients with very early-stage glaucoma, where glaucoma-specific damage has been minimized.</p><p><strong>Methods: </strong>The retinal vascular effects of latanoprost versus the dorzolamide-timolol fixed combination were evaluated using Optical Coherence Tomography Angiography (OCT-A) in a case-control study design. A total of 71 eyes from 71 individuals were included in the study: 28 eyes receiving latanoprost (Group 1), 20 eyes receiving the dorzolamide-timolol combination (Group 2), and 23 eyes from healthy individuals (Group 3). Superficial, deep, and radial peripapillary capillary plexus vascular density (SCP-vd, DCP-vd, RPCP-vd) and foveal avascular zone (FAZ) measurements were taken with OCT-A. The comparative analysis between groups was performed with SPSS V.26.</p><p><strong>Results: </strong>Across the groups (from 1 to 3), whole image vascular density (vd) measurements were as follows: SCP-vd: 45.86 ± 3.99, 44.58 ± 4.58, 48.35 ± 4.04; DCP-vd: 44.86 ± 5.75, 44.02 ± 6.87, 49.74 ± 4.84; and RPCP-vd: 46.97 ± 3.81, 47.07 ± 5.49, 49.90 ± 2.43. All these measurements were significantly decreased in both glaucoma groups (groups 1 and 2) compared to healthy subjects (group 3). In subgroup analyses of the macular region, including the fovea, parafovea, and perifovea, vd measurements were decreased in all areas except the fovea in glaucoma patients. However, no statistically significant differences were found between the latanoprost and dorzolamide-timolol groups regarding retinal vascular structure. In FAZ measurements, no significant differences were found in any anatomical location among the three groups.</p><p><strong>Conclusion: </strong>This study demonstrates that latanoprost, the first prostaglandin analog known for its edema-inducing effect on the macula, does not have a long-term impact on macular vascularity. However, this result should be supported with longer and larger studies.</p>","PeriodicalId":14473,"journal":{"name":"International Ophthalmology","volume":"45 1","pages":"188"},"PeriodicalIF":1.4000,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10792-025-03556-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To assess the macular vascular effects of prolonged use of latanoprost compared to the dorzolamide-timolol fixed combination in patients with very early-stage glaucoma, where glaucoma-specific damage has been minimized.

Methods: The retinal vascular effects of latanoprost versus the dorzolamide-timolol fixed combination were evaluated using Optical Coherence Tomography Angiography (OCT-A) in a case-control study design. A total of 71 eyes from 71 individuals were included in the study: 28 eyes receiving latanoprost (Group 1), 20 eyes receiving the dorzolamide-timolol combination (Group 2), and 23 eyes from healthy individuals (Group 3). Superficial, deep, and radial peripapillary capillary plexus vascular density (SCP-vd, DCP-vd, RPCP-vd) and foveal avascular zone (FAZ) measurements were taken with OCT-A. The comparative analysis between groups was performed with SPSS V.26.

Results: Across the groups (from 1 to 3), whole image vascular density (vd) measurements were as follows: SCP-vd: 45.86 ± 3.99, 44.58 ± 4.58, 48.35 ± 4.04; DCP-vd: 44.86 ± 5.75, 44.02 ± 6.87, 49.74 ± 4.84; and RPCP-vd: 46.97 ± 3.81, 47.07 ± 5.49, 49.90 ± 2.43. All these measurements were significantly decreased in both glaucoma groups (groups 1 and 2) compared to healthy subjects (group 3). In subgroup analyses of the macular region, including the fovea, parafovea, and perifovea, vd measurements were decreased in all areas except the fovea in glaucoma patients. However, no statistically significant differences were found between the latanoprost and dorzolamide-timolol groups regarding retinal vascular structure. In FAZ measurements, no significant differences were found in any anatomical location among the three groups.

Conclusion: This study demonstrates that latanoprost, the first prostaglandin analog known for its edema-inducing effect on the macula, does not have a long-term impact on macular vascularity. However, this result should be supported with longer and larger studies.

长期使用拉坦前列素从血管角度探讨黄斑囊样水肿的线索。
目的:评估长期使用拉坦前列素对极早期青光眼患者黄斑血管的影响,与多唑胺-替洛尔固定联合治疗相比,后者青光眼特异性损伤已被最小化。方法:在病例对照研究设计中,使用光学相干断层扫描血管造影(OCT-A)评估拉坦前列素与多唑胺-替洛尔固定组合对视网膜血管的影响。研究共纳入71例患者的71只眼:28只眼接受拉坦前列素治疗(第一组),20只眼接受多唑胺-替洛尔联合治疗(第二组),23只眼来自健康个体(第三组)。用OCT-A测量浅、深、径向乳头周围毛细血管丛血管密度(SCP-vd, DCP-vd, rcpp -vd)和中央凹无血管带(FAZ)。采用SPSS V.26软件进行组间比较分析。结果:各组(1 ~ 3)全像血管密度(vd)测量值如下:SCP-vd: 45.86±3.99,44.58±4.58,48.35±4.04;DCP-vd: 44.86±5.75,44.02±6.87,49.74±4.84;和RPCP-vd: 46.97±3.81,47.07±5.49,49.90±2.43。与健康受试者(3组)相比,两组青光眼患者(1组和2组)的所有这些指标均显著降低。在黄斑区域的亚组分析中,包括中央凹、中央凹旁和中央凹周围,除了青光眼患者的中央凹外,所有区域的vd测量值都降低了。然而,拉坦前列素组和多唑胺-噻洛尔组在视网膜血管结构方面没有统计学差异。在FAZ测量中,三组在任何解剖位置均无显著差异。结论:本研究表明,拉坦前列素(latanoprost),第一种已知对黄斑有致水肿作用的前列腺素类似物,对黄斑血管没有长期影响。然而,这一结果应该得到更长期、更大规模研究的支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
0.00%
发文量
451
期刊介绍: International Ophthalmology provides the clinician with articles on all the relevant subspecialties of ophthalmology, with a broad international scope. The emphasis is on presentation of the latest clinical research in the field. In addition, the journal includes regular sections devoted to new developments in technologies, products, and techniques.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信